RecruitingNCT06935864
Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
The Prognostic Value of Tissue Expression of Krüppel-Like Factors 4 and 7 in Bone Tumors
Sponsor
Ain Shams University
Enrollment
30 participants
Start Date
Aug 16, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The current study is to assess the prognostic value of Krüppel-like factors 4 and 7 in bone tumors, and its role in the disease progression.
Eligibility
Min Age: 1 MonthMax Age: 39 Years
Inclusion Criteria1
- Age: children, young adolescents younger than 15 years, and young adults (15 to 39 years) Gender: Males and female. Histologically confirmed patients with skeletal or extra-skeletal OS or ES. Both localized and metastatic disease stages.
Exclusion Criteria1
- Patients with second malignant bone sarcoma. Patients with benign bone tumors.
Interventions
DIAGNOSTIC_TESTKLF factor (4 and 7)
Immunohistochemical staining of 4 um sections prepared from paraffin blocks using KLF factor (4 and 7) by automated immunostaining using the streptavidin-biotin technique.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06935864
Related Trials
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
NCT071442541 location
A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma
NCT066505141 location